Close
![image](https://www.vitruvianpartners.com/wp-content/uploads/2021/09/oxford_biomedica@2x-700x175.png)
Oxford Biomedica
Leading lentiviral vector CDMO and technology platform
Life Sciences & Healthcare
United Kingdom & Ireland
Leader in lentiviral vector technology, the predominant transfection technology for the rapidly growing CAR-T therapy space.